» Articles » PMID: 22204322

Current Research on Opioid Receptor Function

Overview
Specialty Pharmacology
Date 2011 Dec 30
PMID 22204322
Citations 104
Authors
Affiliations
Soon will be listed here.
Abstract

The use of opioid analgesics has a long history in clinical settings, although the comprehensive action of opioid receptors is still less understood. Nonetheless, recent studies have generated fresh insights into opioid receptor-mediated functions and their underlying mechanisms. Three major opioid receptors (μ-opioid receptor, MOR; δ-opioid receptor, DOR; and κ-opioid receptor, KOR) have been cloned in many species. Each opioid receptor is functionally sub-classified into several pharmacological subtypes, although, specific gene corresponding each of these receptor subtypes is still unidentified as only a single gene has been isolated for each opioid receptor. In addition to pain modulation and addiction, opioid receptors are widely involved in various physiological and pathophysiological activities, including the regulation of membrane ionic homeostasis, cell proliferation, emotional response, epileptic seizures, immune function, feeding, obesity, respiratory and cardiovascular control as well as some neurodegenerative disorders. In some species, they play an essential role in hibernation. One of the most exciting findings of the past decade is the opioid-receptor, especially DOR, mediated neuroprotection and cardioprotection. The upregulation of DOR expression and DOR activation increase the neuronal tolerance to hypoxic/ischemic stress. The DOR signal triggers (depending on stress duration and severity) different mechanisms at multiple levels to preserve neuronal survival, including the stabilization of homeostasis and increased pro-survival signaling (e.g., PKC-ERK-Bcl 2) and antioxidative capacity. In the heart, PKC and KATP channels are involved in the opioid receptor-mediated cardioprotection. The DOR-mediated neuroprotection and cardioprotection have the potential to significantly alter the clinical pharmacology in terms of prevention and treatment of life-threatening conditions like stroke and myocardial infarction. The main purpose of this article is to review the recent work done on opioids and their receptor functions. It shall provide an informative reference for better understanding the opioid system and further elucidation of the opioid receptor function from a physiological and pharmacological point of view.

Citing Articles

Involvement of central opioid and melanocortin receptors in spexin-induced hypophagia following intracerebroventricular injection in neonatal broiler chicks.

Badri M, Alimohammadi S, Zendehdel M, Hassanpour S BMC Vet Res. 2025; 21(1):110.

PMID: 40011886 PMC: 11863689. DOI: 10.1186/s12917-025-04564-8.


Discovery of rhynchophylline and mitraphylline in two Thai Mitragyna species and the investigation of their biological activity via opioid gene expression analysis.

Sudmoon R, Tanee T, Wonok W, Ameamsri U, Liehr T, Daduang S Sci Rep. 2025; 15(1):5865.

PMID: 39966542 PMC: 11836046. DOI: 10.1038/s41598-025-89715-5.


Pharmacological modulation of respiratory control: Ampakines as a therapeutic strategy.

Rana S, Fusco A, Witkin J, Radin D, Cerne R, Lippa A Pharmacol Ther. 2024; 265:108744.

PMID: 39521442 PMC: 11849399. DOI: 10.1016/j.pharmthera.2024.108744.


Risk of infections among persons treated with opioids for chronic pain: a systematic review and meta-analysis protocol.

Kudrina I, Page M, Choiniere M, Shir Y, Eisenberg M, Ben-Sasson M BMJ Open. 2024; 14(10):e083791.

PMID: 39414287 PMC: 11481125. DOI: 10.1136/bmjopen-2023-083791.


Methadone directly impairs central nervous system cells in vitro.

De Gregorio C, Gallardo J, Berrios-Carcamo P, Handy A, Santapau D, Gonzalez-Madrid A Sci Rep. 2024; 14(1):16978.

PMID: 39043899 PMC: 11266518. DOI: 10.1038/s41598-024-67860-7.


References
1.
Balboni G, Onnis V, Congiu C, Zotti M, Sasaki Y, Ambo A . Effect of lysine at C-terminus of the Dmt-Tic opioid pharmacophore. J Med Chem. 2006; 49(18):5610-7. PMC: 2533050. DOI: 10.1021/jm060741w. View

2.
Scoto G, Arico G, Ronsisvalle S, Parenti C . Blockade of the nociceptin/orphanin FQ/NOP receptor system in the rat ventrolateral periaqueductal gray potentiates DAMGO analgesia. Peptides. 2007; 28(7):1441-6. DOI: 10.1016/j.peptides.2007.05.013. View

3.
Marczak E, Jinsmaa Y, Myers P, Blankenship T, Wilson R, Balboni G . Orally administered H-Dmt-Tic-Lys-NH-CH2-Ph (MZ-2), a potent mu/delta-opioid receptor antagonist, regulates obese-related factors in mice. Eur J Pharmacol. 2009; 616(1-3):115-21. PMC: 2750889. DOI: 10.1016/j.ejphar.2009.06.041. View

4.
Harrison L, Kastin A, Zadina J . Opiate tolerance and dependence: receptors, G-proteins, and antiopiates. Peptides. 1998; 19(9):1603-30. DOI: 10.1016/s0196-9781(98)00126-0. View

5.
Bai H, Du J, Zheng X . [Beta-endorphin involved in the regulation of humoral immune function of rats during acute hypoxia]. Sheng Li Xue Bao. 2001; 51(3):258-62. View